| Safety of Urate Elevation in Parkinson's Disease | A Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial of Oral Inosine to Assess Safety and Ability to Elevate Urate in Early Parkinson's Disease | NCT00833690 |
| An open-label, single-centered, non-randomized trial of inosine to assess its safety for patients with Parkinson's disease | An open-label, single-centered, non-randomized trial of inosine to assess its safety for patients with Parkinson's disease - An evaluation of the safety of inosine for patients with Parkinson's disease | JPRN-UMIN000009062 |
| A Pilot Study of Inosine in Amyotrophic Lateral Sclerosis (ALS) | A Pilot Study of Inosine in Amyotrophic Lateral Sclerosis (ALS) | NCT02288091 |
| A Food-Drug Interaction Study of Serum Urate After Oral Inosine | A Phase 1, Open-label, Randomized, Two-period, Two-treatment, Crossover Study to Evaluate the Effects of Food on the Pharmacokinetics of Urate After a Single Dose of Inosine in Healthy Male Subjects | NCT02614469 |
| The influence of genetic variants on inosine-induced hyperuricaemia | The influence of genetic variants on inosine-induced hyperuricaemia in healthy adult volunteers | ACTRN12615001302549 |
| Study of Urate Elevation in Parkinson's Disease, Phase 3 | A Randomized, Double-blind, Placebo-controlled Trial of Urate-elevating Inosine Treatment to Slow Clinical Decline in Early Parkinson's Disease | NCT02642393 |
| Multi-centered, placebo-controlled, double-blind, randomized clinical trial to assess the effect of oral inosine on the onset of wearing off in patients with early stage Parkinson's disease | Multi-centered, placebo-controlled, double-blind, randomized clinical trial to assess the effect of oral inosine on the onset of wearing off in patients with early stage Parkinson's disease - Randomized clinical trial to assess the disease modifying effect of oral inosine for patients with Parkinson's disease | JPRN-UMIN000020527 |
| Study on efficacy and safety of combination treatment with febuxostat and inosine for patients with heart failure | Study on efficacy and safety of combination treatment with febuxostat and inosine for patients with heart failure - Effect of febuxostat and inosine on heart failure | JPRN-UMIN000025427 |
| Clinical study to examine the changes of purine compounds by the simultaneous administration of xanthine oxidase/xanthine dehydrogenase inhibitors and inosine in healthy subjects. | Clinical study to examine the changes of purine compounds by the simultaneous administration of xanthine oxidase/xanthine dehydrogenase inhibitors and inosine in healthy subjects. - Study of XO/XDH inhibitors and inosine in healthy subjects | JPRN-UMIN000024027 |
| Studies of efficacy and safety of simultaneous administration of febuxostat and inosine for patients with genetic anemia, and changes of blood and urine purine compounds | Studies of efficacy and safety of simultaneous administration of febuxostat and inosine for patients with genetic anemia, and changes of blood and urine purine compounds - Effect of febuxostat and inosine on anemia | JPRN-UMIN000024750 |
| Studies of efficacy and safety of the combined use of febuxostat and inosine for patients with Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis or multiple sclerosis, and changes of blood and urine purine compounds. | Studies of efficacy and safety of the combined use of febuxostat and inosine for patients with Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis or multiple sclerosis, and changes of blood and urine purine compounds. - Effect of febuxostat and inosine on CNS diseases | JPRN-UMIN000024312 |
| Inosine Reverse Chemo Resistance in Triple Negative Breast Cancer | a Pilot Study to Explore the Efficacy of Inosine Reversing Chemo Resistance in Triple Negative Breast Cancer | NCT06355024 |
| Effects of Inosine Supplements on Markers of Bone Health | Effects of oral inosine supplements on bone turnover markers in healthy post-menopausal women | ACTRN12617000940370 |
| Inosine 5'-Monophosphate to Raise of Serum Uric Acid Level in Patients With Multiple System Atrophy: a Multi-center, Randomized Controlled, Double Blind, Parallel Assigned Clinical Trial | Inosine 5'-Monophosphate to Raise of Serum Uric Acid Level in Patients With Multiple System Atrophy: a Multi-center, Randomized Controlled, Double Blind, Parallel Assigned Clinical Trial (IMPROVE MSA Study) | NCT03403309 |
| Efficacy and safety of antidepressant combined with inosine for depressive disorders in children, adolescents and adults: a randomised, double-blind, placebo-controlled trial | Efficacy and safety of antidepressant combined with inosine for depressive disorders in children, adolescents and adults: a randomised, double-blind, placebo-controlled trial | ChiCTR1800014637 |
| Study on efficacy and safety as well as on the changes in blood purine compounds by the treatment of patients with amyotrophic lateral sclerosis with febuxostat and inosine in combination. | Study on efficacy and safety as well as on the changes in blood purine compounds by the treatment of patients with amyotrophic lateral sclerosis with febuxostat and inosine in combination. - Effect of febuxostat and inosine on amyotrophic lateral sclerosis | JPRN-UMIN000029308 |
| Study on efficacy and safety of the simultaneous treatment with febuxostat and inosine of patients with Parkinson's disease. | Study on efficacy and safety of the simultaneous treatment with febuxostat and inosine of patients with Parkinson's disease. - Effect of febuxostat and inosine on Parkinson's disease | JPRN-UMIN000030930 |
| Randomized clinical trial to assess the disease modifying effect of oral inosine for patients with Parkinson's disease | Multi-centered, placebo-controlled, double-blind, randomized clinical trial to assess the effect of oral inosine on the onset of wearing off in patients with early stage Parkinson's disease - Multi-centered, placebo-controlled, double-blind, randomized clinical trial to assess the effect of oral inosine on the onset of wearing off in patients with early stage Parkinson's disease | JPRN-jRCTs061180060 |
| PK & PD of coadministration of XOR inhibitor and inosine | Pharmacokinetics and pharmacodynamics study of coadministration of either allopurinol or febuxostat and inosine | JPRN-jRCTs031190115 |
| Inosine Energy Expenditure Study | Randomized Cross-over Trial to Investigate the Effect of Inosine on Human Energy Expenditure | NCT04476238 |
| A clinical study to understand the effect of Inosine Pranobex in Covid-19 patients when used along with the standard of Care in Covid patients. | An Open-Label, Prospective, Randomized, Comparative, Parallel Group, Multi-Center, Proof of Concept Study to Assess the Efficacy and Safety of Inosine Pranobex Added to Current Standard of Care (CSC) in COVID-19 Patients. | CTRI/2020/08/027162 |
| A clinical study to understand the effect of Inosine Pranobex in Covid-19 patients when used along with the defined standard of Care in Covid patients | A Phase 3, Double-Blind, Placebo-Controlled, Prospective, Randomized, Comparative, Parallel Group, Multi-Centre, Study to Assess the Efficacy and Safety of Inosine Pranobex Added to a Defined Standard of Care in Covid-19 Patients. | CTRI/2021/02/030892 |
| Serum uric acid change after oral inosine administration | Serum uric acid change after oral inosine administration | ChiCTR2200061080 |
| Studies of efficacy and safety of the combined use of febuxostat and inosine for patients with glucose intolerance, and changes of blood and urine purine compounds. | Studies of efficacy and safety of the combined use of febuxostat and inosine for patients with glucose intolerance, and changes of blood and urine purine compounds. - Effect of febuxostat and inosine on glucose intolerance | JPRN-UMIN000024316 |
| Treatment of Multiple Sclerosis Using Over the Counter Inosine | Treatment of Multiple Sclerosis Using Over the Counter Inosine | NCT00067327 |
| To Assess the Safety, Tolerability and Efficacy of Inosine Pranobex Tablets in Patients with Influenza and Other Acute Respiratory Viral Infections. | A Phase IV, Prospective, Multi-centre, Open label, Randomized Two-Arm Study to Assess the Safety, Tolerability and Efficacy of Inosine Pranobex 500 and 1000 mg Tablets Manufactured by Themis Medicare Ltd in Patients with Influenza and Other Acute Respiratory Viral Infections. - NIL | CTRI/2024/12/077666 |
| Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen | Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen: Monophosphoryl lipidA, Poly-inosine-cytosine, Poly-inosine-cytosine Stabilised With Poly-L-lysine and Carboxymethylcellulose, Resiquimod, Tuberculin and Timothy Grass Pollen | NCT02090374 |
